Company: STAA
Filing Date: 2025-02-21
Form Type: 10-K
Source: 0000950170-25-024813
Chunk: 107

Company: STAAR SURGICAL CO
Filing Date: 2025-02-21
Form: 10-K
Item: Item 1B
Chunk 107
---
103

    143,548

    17,121

    Proceeds from sale of investments available for sale

    1,314

    1,300

    359

    Net cash provided by (used in) investing activities

    (59,217
    )

    74,347

    (156,376
    )

    Cash flows from financing activities:

    Repayment of finance lease obligations

    (165
    )

    (161
    )

    (126
    )

    Repurchase of employee common stock for taxes withheld

    (1,505
    )

    (2,097
    )

    —

    Proceeds from the exercise of stock options

    7,392

    9,672

    8,422

    Proceeds from vested restricted stock

    2

    1

    1

    Net cash provided by financing activities

    5,724

    7,415

    8,297

    Effect of exchange rate changes on cash and cash equivalents

    (1,111
    )

    202

    (862
    )

    Increase (decrease) in cash and cash equivalents

    (38,879
    )

    96,558

    (113,226
    )

    Cash and cash equivalents, at beginning of year

    183,038

    86,480

    199,706

    Cash and cash equivalents, at end of year
     
    $
    144,159

    $
    183,038

    $
    86,480

The accompanying notes are an integral part of these consolidated financial statements.

F-8

STAAR SURGICAL COMPANY AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Organization and Description of Business and Accounting PoliciesOrganization and Description of BusinessSTAAR Surgical Company, a Delaware corporation, was first incorporated in 1982, and together with its subsidiaries (the “Company”) designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company generates worldwide revenue almost exclusively from sales of its implantable Collamer lenses (“ICLs”), which are used in corrective or “refractive” surgery. Historically, the Company also manufactured and sold intraocular lenses (“IOLs”), for use in surgery to treat c